Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
Health
Page 2
STOCK TICKER: Blumenthal’s Wife Invests in Biotech Hedge Fund as He Chairs Panel Overseeing Drug Prices
As a consumer protection subcommittee chairman, Blumenthal has focused on the role pharmaceutical benefit managers play in driving up the cost of drugs.
Drug Lobby Revenues Skyrocket During Covid Pandemic
Lobbying giant PhRMA reported revenues of more than $600 million in 2021, a new record for the group.
With Abortion Access at Stake, These Companies Donated to Anti-Choice Georgia Republican AG Chris Carr
Carr squeaked out a re-election win over a Democratic rival who pledged that she would not enforce Georgia's "heartbeat law" abortion ban.
Sugar Industry-Backed Senators Urge No Action on High Sugar Prices
In a letter to Ag Secretary Tom Vilsack, the senators warn against changing the programs that jack up prices for American sugar.
Pharma Lobby Enlists Minority Groups to Fight Drug Pricing Reform
PhRMA-funded groups the National Hispanic Council on Aging and the National Minority Quality Forum say most voters of color do not support the Democrats' drug pricing reform proposal.
Corporate America Butters Up Likely Next Energy and Commerce Chair
Rep. Cathy McMorris Rodgers (R-Wash.), the ranking member of the Energy and Commerce Committee, has received more business PAC donations this election cycle than any other House candidate.
Florida GOP Deregulates Nursing Homes
Florida’s Republican politicians are shielding their campaign donors from liability while chipping away at safety standards for elderly residents.
Pharma Lobbyist-Run Group Places $300k Ad Buy for Kurt Schrader
The dark-money group Center Forward, which is buying the ads, has received millions from the pharmaceutical industry in recent years.
Biden’s Big Pharma Pick for FDA Could Squeak Through With Help From Pharma-Funded Republicans
Four Republicans with extensive ties to the pharmaceutical industry have already said they plan to cross the aisle and support Califf's confirmation to be commissioner of the Food and Drug Administration.